Direct left ventricular endocardial pacing: an alternative when traditional resynchronization via coronary sinus is

Pablo Moriña-Vázquez1, Jessica Roa-Garrido, Juan M Fernández-Gómez

  • 1Pacing and Arrhythmia Department, Juan Ramón Jiménez Hospital, Huelva, Spain. pmorina@gmail.com

Insights

Direct left ventricular (LV) endocardial pacing offers a safe and effective alternative for heart failure patients when coronary sinus (CS) biventricular pacing fails. This technique provides improved outcomes and may be less risky than surgical epicardial lead implantation.

Area of Science:

  • Cardiology
  • Medical Devices
  • Electrophysiology

Background:

  • Biventricular pacing via coronary sinus (CS) is a standard treatment for heart failure with left bundle-branch block.
  • CS pacing is not always feasible, and surgical epicardial lead implantation carries risks.
  • Direct left ventricular (LV) endocardial pacing presents a potential alternative.

Purpose of the Study:

  • To describe the technique of direct LV endocardial pacing.
  • To analyze the outcomes of this novel pacing method in patients with failed CS resynchronization.

Main Methods:

  • Retrospective analysis of 14 patients who underwent direct LV endocardial pacing after failed CS attempts.
  • Utilized a femoral approach with transseptal puncture and LV mapping for lead placement.
  • Generator placement in the anterior thigh; VVT mode used for subclavian-sensed pacing or complete femoral systems.

Main Results:

  • Successful LV lead implantation in all patients.
  • Significant improvement in New York Heart Association class and left ventricle ejection fraction in most patients.
  • Two patients experienced bleeding complications; two died during follow-up. One patient with ventricular fibrillation remained asymptomatic.

Conclusions:

  • Direct LV endocardial pacing is a safe and feasible alternative for cardiac resynchronization therapy.
  • This technique may offer a less risky and more efficient option compared to surgical epicardial lead implantation.
  • Demonstrates potential for improved patient outcomes in challenging resynchronization cases.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...